BioGen’s 2026 IP Crisis: A Biotech Warning
BioGen's patent battle over a gene therapy highlights biotech IP risks. Learn 4 proactive steps to protect innovation from multinational giants.
BioGen's patent battle over a gene therapy highlights biotech IP risks. Learn 4 proactive steps to protect innovation from multinational giants.
Will central banks' shift to hybrid cloud risk financial stability by 2026? Learn how data sovereignty plans can prevent this.
2026 brought negative Part D premiums for some. Learn why insurers are paying beneficiaries due to the Inflation Reduction Act's $2,000 cap.
How can governments use fiscal policy to counter 2026 energy price shocks? Learn about targeted subsidies, renewables, and carbon pricing.
Germany's AfD presents a controversial economic vision. Learn their plans for immigration, Eurozone, taxes, and energy, and why it matters for Europe.
The EU AI Act brings new rules for AI like Aura. See how regulations affect global tech expansion and what innovators must do to comply.
Gene-edited foods promise benefits, but labeling lags. Will clear rules emerge by 2026 to build trust? See why 67% of US adults support it.
New drug prices topped $220,000 in 2023. See why millions skip care due to cost and how the Inflation Reduction Act aims to help.
340B audits are up 15%, bringing $500K non-compliance fines. See why HRSA scrutiny is growing and how to reduce your organization's risk.
What's next for North American trade under USMCA? See key changes from NAFTA, including 75% auto content rules, and what to watch for by 2026.